Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 209 of 6351
-
Antibiotic shield: doxycycline may stop STIs in young women
Prevention Recruiting nowThe goal of this open-label, randomized trial is to assess the efficacy of doxycycline prophylaxis in reducing incidences of bacterial sexually transmitted infections (STIs) among adolescent and young adult females while also evaluating acceptability and antimicrobial resistance …
Phase 4 • Sponsor: Westat • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
New drug combo aims to shrink tumors in advanced breast cancer
Disease control Recruiting nowThe study is being conducted to evaluate the clinical efficacy of HLX22 in combination with HLX87 as first-line treatment in patients with HER2-positive recurrent or metastatic breast cancer
Phase 2/3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
New targeted drug combo aims to curb relapse in kids with rare immune disorder
Disease control Recruiting nowLangerhans cell histiocytosis (LCH) is the most common histiocytic disorder in children, caused by excessive proliferation and accumulation of Langerhans cells (a type of immune cell) in various body tissues. The annual incidence is about 2.6-8.9 cases per million children.Clinic…
Sponsor: West China Second University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New weekly shot aims to treat sleep apnea and obesity together
Disease control Recruiting nowThe purpose of the studies is to evaluate the efficacy and safety of eloralintide in participants with moderate-to-severe obstructive sleep apnea and obesity or overweight. YDAO is a master protocol designed to support two independent studies: YSA1 and YSA2. Study YSA1 will inclu…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could white blood cells boost cord transplants for tough leukemia?
Disease control Not yet recruitingAllogeneic stem cell transplantation is the only potentially curative therapy for patients with high-risk Acute Myeloid Leukaemia, but relapse is common and remains the leading cause of death. Patients with certain mutations and those transplanted without first clearing their dis…
Phase 1/2 • Sponsor: University of Manchester • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
CAR t cells aim to lock in remission for leukemia patients
Disease control Recruiting nowThe researchers are doing this study to find out whether obecabtagene autoleucel (obe-cel) is an effective treatment for people with B-cell acute lymphoblastic leukemia (ALL) that is in complete remission (CR, meaning all signs of cancer are gone) with no measurable residual dise…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can one small incision replace multiple for lung cancer surgery?
Disease control Recruiting nowEarly-stage lung cancer represents a clinical challenge that, when diagnosed promptly, offers high chances of cure through lobectomy and lymphadenectomy. In addition to traditional surgery, robotic techniques have become established and have recently evolved further with the Sing…
Sponsor: European Institute of Oncology • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Engineered immune cells take on tough lupus cases
Disease control Recruiting nowThis is an investigator-initiated trial aimed at assessing the safety and efficacy of PTOC1 cells Injection in the treatment of refractory systemic lupus erythematosus.
Phase 1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Immunotherapy combo shows promise in battling esophageal cancer before surgery
Disease control Not yet recruitingThis study is a randomized, controlled, open-label, multicenter Phase III clinical trial, designed to evaluate the efficacy and safety of neoadjuvant toripalimab in combination with nab-paclitaxel and platinum versus neoadjuvant docetaxel in combination with cisplatin and 5-fluor…
Phase 3 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
AI reads chest X-Rays to catch kawasaki disease earlier in kids
Diagnosis Not yet recruitingThe goal of this observational study is to develop an AI-based early warning system for Kawasaki Disease (KD) using chest X-rays (CXR) in children diagnosed with Kawasaki Disease. The main question\[s\] it aims to answer are: 1. Can AI modeling of CXR features help identify high…
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
New combo therapy aims to boost survival in head and neck cancer patients
Disease control Not yet recruitingThis is a prospective, randomized, controlled, multicenter, non-inferiority clinical study designed to evaluate the efficacy and safety of camrelizumab combined with EGFR monoclonal antibody or chemotherapy as perioperative treatment of locally advanced head and neck squamous cel…
Phase 3 • Sponsor: Yue He, MD • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New combo aims to beat rectal cancer without surgery
Disease control Recruiting nowIn pMMR/MSS locally advanced rectal cancer, can the innovative "chemo-immunotherapy induction + LCRT + chemo-immunotherapy consolidation" approach significantly improve the complete response rate and create opportunities for organ preservation?
Phase 2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Predicting the unpredictable: new model aims to forecast brain bleeds in moyamoya
Knowledge-focused Recruiting nowIntracranial hemorrhage is a leading cause of death and disability in patients with moyamoya disease (MMD), yet clinically available tools for predicting long-term hemorrhage risk are lacking. Dilatation and rupture of fragile collateral vessels are considered the main cause of M…
Sponsor: Beijing Hospital • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Engineered immune cells take on lupus and other autoimmune diseases
Disease control Not yet recruitingThe purpose of this study is to assess the safety and efficacy of CD19 UCAR-T cell therapy in Subjects with autoimmune diseases.
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could KarXT be the key to treating teen schizophrenia?
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of KarXT for treatment of Schizophrenia in adolescents.
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Eye implant could restore sight after retinal vein blockage
Disease control Recruiting nowThis is a multicenter, randomized, double-masked, parallel-group, active-controlled Phase 3 clinical trial designed to evaluate the efficacy and safety of SMO1 (Dexamethasone 700μg intravitreal implant) compared with the reference drug (Dexamethasone 700μg intravitreal implant) i…
Phase 3 • Sponsor: SANGMYUNG innovation • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can morning light and melatonin double the power of antidepressants?
Disease control Recruiting nowMajor Depressive Disorder (MDD) affects 5% of the global population and is the second leading cause of disability worldwide. Despite the widespread use of antidepressants, 50-60% of patients do not respond adequately after 8 weeks of treatment. Insomnia, present in approximately …
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a High-Tech CPR bundle boost heart restart rates?
Disease control Recruiting nowThe goal of this controlled single centre RCT is to compare frequency rates concerning return of spontaneous circulation (ROSC) in prehospital cardiac arrest. Two different algorithms (control-and interventiongroup) of advanced cardiac life support will be used to treat patients.…
Sponsor: Johannes Kepler University of Linz • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a simple fertility procedure break the cycle of unexplained pregnancy loss?
Disease control Recruiting nowUnexplained pregnancy loss remains a major reproductive challenge, and effective management strategies for affected couples are limited. Although intrauterine insemination (IUI) is widely used in reproductive medicine, its effectiveness in improving subsequent pregnancy outcomes …
Sponsor: Lanzhou University Second Hospital • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New immune cell therapy takes on childhood cancers that Won't quit
Disease control Recruiting nowThis is a phase I dose-escalation study to determine the safety and feasibility of autologous CAR-TA T cells (B7-H3 CAR+ T cells administered with DNR-PRAME Tumor Antigen-specific T cells) following lymphodepleting chemotherapy in participants with relapsed/refractory rhabdomyosa…
Phase 1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC